Montirelin

Montirelin stimulates the release of thyrotropin and prolactin. It is synthesized by the neurons in the paraventricular nucleus of the hypothalamus. After being released into the pituitary portal circulation, TRH (was called TRF) stimulates the release of TSH and PRL from the anterior pituitary gland.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: 10-101-64

CAS No:62305-91-3

Synonyms/Alias:CG 3703; CG-3703; CG3703; CNK 602A; CNK602A; CNK-602A; CNK 603; CNK603; CNK-603; NS-3; NS3; NS 3; PS 24; Montirelin; Montireline; Montirelinum; Montirelin; Montirelina; CCRIS 7571; CCRIS7571

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C17H24N6O4S
M.W/Mr.
408.48
Sequence
6-Me-5-oxothiomorpholinyl-3-carbonyl-His-Pro-NH2
Labeling Target
Thyrotrophin releasing hormone (TRH) receptor
Application
Montirelin is a potent, biologically stable TRH analog for brain receptor binding.
Activity
Agonist
Areas of Interest
Hormonal therapy
Source#
Synthetic
Solubility
−20°C
InChI
InChI=1S/C17H24N6O4S/c1-9-15(25)22-12(7-28-9)16(26)21-11(5-10-6-19-8-20-10)17(27)23-4-2-3-13(23)14(18)24/h6,8-9,11-13H,2-5,7H2,1H3,(H2,18,24)(H,19,20)(H,21,26)(H,22,25)/t9?,11-,12?,13-/m0/s1
InChI Key
RSHMQGIMHQPMEB-VEEXIGFHSA-N
Isomeric SMILES
CC1C(=O)NC(CS1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N
BoilingPoint
994.2±65.0 °C at 760 mmHg
References

The histaminergic tuberomamillary nucleus (TMN) controls arousal and attention and the firing of TMN neurons is state-dependent, active during waking, silent during sleep. Thyrotropin-releasing hormone (TRH) promotes arousal and combats sleepiness associated with narcolepsy. Single-cell RT-PCR (scRT-PCR) demonstrated variable expression of the two known TRH receptors in the majority of TMN neurons. TRH increased the firing rate of most (ca 70%) TMN neurons. This excitation was abolished in the presence of the TRH receptor antagonist chlordiazepoxide (50 μM). In the presence of tetrodotoxin TRH depolarized TMN neurons without changing their input resistance. This effect reversed at the potential typical for nonselective cation channels. The potassium channel blockers barium and cesium did not influence the TRH-induced depolarization. TRH effects were antagonized by inhibitors of the Na+/Ca2+ exchanger, KB-R7943 and benzamil. The frequency of spontaneous inhibitory GABAergic postsynaptic potentials was either increased (TTX-insensitive) or decreased (TTX-sensitive GABA release sites) by TRH, indicating a heterogeneous modulation of GABAergic inputs by TRH. Montirelin (TRH analogue, 1 mg/kg ip) induced waking in wild type mice but not in histidine decarboxylase knockout mice lacking histamine. Inhibition of histamine synthesis by (S)-α-fluoromethylhistidine blocked the arousal effect of montirelin in WT mice. We conclude, that direct excitation of rodent TMN neurons by TRH is receptor-mediated and demands activation of nonselective cation channels as well as electrogenic Na+/Ca2+ exchange. Our findings indicate a key role of histamine in TRH-induced arousal.

Parmentier, R., Kolbaev, S., Klyuch, B. P., Vandael, D., Lin, J. S., Selbach, O., ... & Sergeeva, O. A. (2009). Excitation of histaminergic tuberomamillary neurons by thyrotropin-releasing hormone. Journal of Neuroscience, 29(14), 4471-4483.

Melting Point
N/A

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Modification ServicescGMP Peptide ServicePeptide Synthesis ServicesPeptide CDMOPeptide Nucleic Acids SynthesisPeptide Analysis ServicesCustom Conjugation ServiceEpitope Mapping Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers